News

Most cancers kill because tumor cells spread beyond the primary site to invade other organs. Now, a USC study of brain-invading breast cancer cells circulating in the blood reveals they have a molecular signature indicating specific organ preferences.

Researchers have used 3D printing to integrate living cells into fine structures.

A research team has uncovered a new understanding of how RNA molecules act as cellular "biosensors" to monitor and respond to changes in the environment by controlling gene expression.

A team from the Broad Institute of MIT and Harvard has developed a new CRISPR genome-editing approach by combining two of the most important proteins in molecular biology -- CRISPR-Cas9 and a reverse transcriptase -- into a single machine.

A major new study reveals how socio-economic migration within the UK has affected the geographic distribution of human DNA linked to traits such as education levels and health.

Researchers at the Harvard John A. Paulson School of Engineering and Applied Sciences have grown rabbit and cow muscles cells on edible gelatin scaffolds that mimic the texture and consistency of meat, demonstrating that realistic meat products may eventually be produced without the need to raise and slaughter animals.

"Is it a boy or girl?". It's presumed that there's a 50-50 chance you'd have one or the other. However, a new study of the sex chromosomes suggest they genes which, at least in mice, skew that assumed ratio to favor one sex, could have major implications for male infertility.

The findings of a new study into lung development could help in creating novel treatments for premature babies.

University of Freiburg researchers discover a new principle – how cells protect themselves from mitochondrial defects.

Not-for-profit Jisc and the Microbiology Society announce a pilot transitional open access agreement. The "Publish and Read" deal will allow researchers at participating institutions to publish an unlimited number of open-access articles, as well as access to the society’s full portfolio in return for a cost neutral fixed fee.